Published in Medical Letter on the CDC and FDA, December 21st, 2003
Isolagen collected patient response data from 59 patients randomly chosen from a total of the approximately 400 patients treated to date in the U.K. with the Isolagen Process. This data was independently analyzed by an independent clinical research organization. The preliminary data analysis shows positive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.